MIEF2 and colorectal carcinoma: In conclusion, we identified potential predictors of OXL resistance in CRC, among which MIEF2 may serve as a predictor of OXL drug responsiveness and a potential target for the development of therapies to improve chemotherapy effectiveness in CRC.